David J Ganfield

Title: The Innovative Contributions of David J. Ganfield

David J. Ganfield is an inventive force based in Clementon, New Jersey. With a robust portfolio of three patents, he has made significant strides in the field of immunology and biotechnology.

Latest Patents

Ganfield's latest patents include innovative approaches to producing antibodies against immunogenic peptides. These patents specifically focus on antibodies to a twenty-one acid peptide characterized by the sequence (X-Ser-Tyr-Asn-Leu-Leu-Gly-Phe-Leu-Gln-Arg-Ser-Ser-Asn-Phe-Gln-Y-Gln-Lys-Leu-Leu).sub.n, where X is either Met or Ser and Y may be His or Cys, with n ranging from 1 to 12. In addition to this, he has developed peptide/protein conjugates and corresponding antibodies, along with processes for producing these antibodies. Furthermore, his patents encompass methods for assaying human fibroblast interferon and purifying it, showcasing his expertise in advanced biotechnological methods.

Career Highlights

David J. Ganfield is associated with E.I. du Pont de Nemours and Company, where he contributes to groundbreaking research and development initiatives. His work exemplifies the synergy of science and application, focusing on improving processes and products in the biotechnological landscape.

Collaborations

Throughout his career, Ganfield has collaborated with notable peers, including Michael W. Hunkapiller and Ernest Knight, Jr. These partnerships have facilitated the exchange of ideas and have significantly contributed to his innovative work in immunology.

Conclusion

David J. Ganfield stands out as a distinguished inventor whose ongoing contributions to immunology through his patents play a pivotal role in advancing biotechnological applications. His innovative spirit and collaboration with esteemed colleagues continue to shape the future of research and development in the field.